Stock Analiz

LLY vs ABBV stock comparison

ELI LILLY & Co vs. AbbVie · data as of November 13, 2026

ELI LILLY & Co (LLY) has a market value of about $1.36T, AbbVie (ABBV) about $521.5B. Over their latest twelve months ELI LILLY & Co had revenue of $86.5B and AbbVie $66.0B.

On our five checks ELI LILLY & Co scores higher: 3.4 out of 5 (good) against 1.8 (weak).

By area, the stronger company is ELI LILLY & Co on future growth; ELI LILLY & Co on track record; ELI LILLY & Co on financial health.

ELI LILLY & Co is cheaper on earnings (P/E 46.9 vs. 50.8).

ELI LILLY & Co leads on 14 of the compared lines and AbbVie on 8.

Side by side

LLYABBV
Size and price
Market cap$1.36T$521.5B
Share price$1,443.50$295.03
Score
Overall score (of 5)3.41.8
Value00
Future growth51
Track record52
Financial health32
Shareholder returns44
Valuation
P/E (TTM)46.950.8
Forward P/E30.419.1
Price / free cash flow69.127.6
Price / sales15.77.9
EV / EBITDA37.119.8
PEG1.70—
DCF value vs. price−37%−20%
Business
Revenue$86.5B$66.0B
Net income$27.6B$10.3B
Free cash flow$19.7B$18.9B
Net margin31.9%15.7%
Gross margin (5-yr avg.)78.9%68.3%
ROIC (5-yr avg.)22.9%15.3%
Growth
Revenue growth (1 yr)44.7%8.6%
Revenue growth (5 yrs, per year)21.6%5.9%
EPS growth (5 yrs, per year)27.6%-2.8%
Balance sheet and payouts
Net cash (cash minus debt)-$44.6B-$61.5B
Dividend yield0.48%2.35%
Shareholder yield0.8%2.5%
Analysts
Upside to average target+1%+6%
Consensus ratingBuyBuy

Highlighted = the better figure on that line. Revenue, net income and free cash flow: LLY TTM to September 30, 2026, ABBV TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, ELI LILLY & Co or AbbVie?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) ELI LILLY & Co scores 3.4 out of 5 and AbbVie 1.8; the table shows where each one is stronger.

Is ELI LILLY & Co cheaper than AbbVie?

On trailing earnings, ELI LILLY & Co trades at a P/E of 46.9 and AbbVie at 50.8, so ELI LILLY & Co is cheaper by this measure. A lower P/E can also reflect slower expected growth.

Which grows faster, ELI LILLY & Co or AbbVie?

Over five years ELI LILLY & Co grew revenue about 21.6% a year and AbbVie about 5.9% a year.

Which pays a higher dividend?

ELI LILLY & Co yields 0.48% and AbbVie 2.35%.

Full ELI LILLY & Co analysis → Full AbbVie analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.